CA-27440/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1981	1
1982	1
1983	1
1984	1
1985	1
1986	2
1987	1
1988	1
1989	2
1990	2
1991	2
1992	1
1993	3
1994	2
1995	2
1996	2
1997	2
1998	4
1999	6
2000	3
2003	1
2004	1
2008	1
2021	0

1

Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Njar VC, Brodie AM. Njar VC, et al. Drugs. 1999 Aug;58(2):233-55. doi: 10.2165/00003495-199958020-00003. Drugs. 1999. PMID: 10473018 Review.

2

Aromatase and other inhibitors in breast and prostatic cancer.

Brodie AM, Banks PK, Inkster SE, Son C, Koos RD. Brodie AM, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1043-8. doi: 10.1016/0960-0760(90)90463-u. J Steroid Biochem Mol Biol. 1990. PMID: 2285580 Review.

3

Aromatase, its inhibitors and their use in breast cancer treatment.

Brodie AM. Brodie AM. Pharmacol Ther. 1993 Dec;60(3):501-15. doi: 10.1016/0163-7258(93)90033-a. Pharmacol Ther. 1993. PMID: 8073072 Review.

4

Aromatase and its inhibitors--an overview.

Brodie A. Brodie A. J Steroid Biochem Mol Biol. 1991;40(1-3):255-61. doi: 10.1016/0960-0760(91)90190-g. J Steroid Biochem Mol Biol. 1991. PMID: 1958529 Review.

5

Aromatase inhibitors and breast cancer.

Brodie AM, Njar VC. Brodie AM, et al. Semin Oncol. 1996 Aug;23(4 Suppl 9):10-20. Semin Oncol. 1996. PMID: 8824460 Review.

6

Aromatase in the human testis.

Brodie A, Inkster S. Brodie A, et al. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):549-55. doi: 10.1016/0960-0760(93)90258-x. J Steroid Biochem Mol Biol. 1993. PMID: 8476768

7

Human testicular aromatase: immunocytochemical and biochemical studies.

Inkster S, Yue W, Brodie A. Inkster S, et al. J Clin Endocrinol Metab. 1995 Jun;80(6):1941-7. doi: 10.1210/jcem.80.6.7539819. J Clin Endocrinol Metab. 1995. PMID: 7539819

8

Inhibitors of 17alpha-hydroxylase/17,20-lyase (CYP17): potential agents for the treatment of prostate cancer.

Njar VC, Brodie AM. Njar VC, et al. Curr Pharm Des. 1999 Mar;5(3):163-80. Curr Pharm Des. 1999. PMID: 10066888 Review.

9

Aromatase inhibitors and hormone-dependent cancers.

Brodie AM, Banks PK, Inkster SE, Dowsett M, Coombes RC. Brodie AM, et al. J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):327-33. doi: 10.1016/0960-0760(90)90481-y. J Steroid Biochem Mol Biol. 1990. PMID: 2257237 Review.

10

Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.

Vasaitis T, Belosay A, Schayowitz A, Khandelwal A, Chopra P, Gediya LK, Guo Z, Fang HB, Njar VC, Brodie AM. Vasaitis T, et al. Mol Cancer Ther. 2008 Aug;7(8):2348-57. doi: 10.1158/1535-7163.MCT-08-0230. Mol Cancer Ther. 2008. PMID: 18723482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results